Discover the leading mobile application testing tools for DevOps teams in 2025, aimed at enhancing performance, stability, and agile release cycles for businesses worldwide.

GeeTest, a global leader in bot management and online security solutions serving over 360,000 enterprises worldwide, today highlights its powerful Business Rules Engine. This advanced no-code/low-code ...

While SAS has announced category champions today, the overall SAS Hackathon champion will be named at SAS Innovate 2026, the SAS data and AI conference, April 27-30, 2026, in Grapevine, Texas (near ...

TIOBE Index for December 2025: Top 10 Most Popular Programming Languages Your email has been sent December’s TIOBE Index lands with a quieter top tier but a livelier shuffle just beneath it. The main ...

AI's next wave will be felt on job sites, factory floors, warehouses, and physical environments, says OpenSpace's CEO.

Microsoft has added official Python support to Aspire 13, expanding the platform beyond .NET and JavaScript for building and running distributed apps. Documented today in a Microsoft DevBlogs post, ...

Python gives you far more control, and the ecosystem is stacked with libraries that can replace most no-code platforms if you ...

This is an important study showing that movement vigor is not solely an individual property but emerges through interaction when two people are physically linked. The evidence is convincing, supported ...

A controversy is swirling at a Texas university. The trigger? A flowchart. On Dec. 1, the new chancellor of the Texas Tech University system sent professors a diagram laying out a chain of approval ...

This program aims directly at enabling the whole artist: body, mind, and spirit. We foster the development of soulful artists who make art to nurture and to challenge all that is best in human life.

The FDA has approved its first at-home, nondrug therapy for depression, with a wearable brain stimulation headset developed by Flow Neuroscience. The agency issued a green light that covers the device ...

Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that ...